patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Newbie ?

Yep, I like what I see in this one. I have added to my portfolio, but I have not added any spec stocks in two years due to the high volume of EDIG and moderate volume of PTSC I still hold. I like my chances with both of them and I think I like this one as well. I just need to spend some time with it and get a feel for the timing and the next few company events.

Thanks,

John

Share
New Message
Please login to post a reply